SP1 and head and neck squamous cell carcinoma: These data were also confirmed in shCTR and anti‐miR‐9 CAL27 cells, overexpressing or not Sp1 (Fig EV2C and D), supporting that Sp1 may represent a major contributor to the miR‐9‐mediated resistance to EGFR blockade observed in HNSCC.